Health Technology · Pharmaceuticals: Other · NSE: SHRIAHIMSA · data 2026-10-09

Shri Ahimsa Naturals Limited

Health check: Average (6.3/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹421.95

Market cap

₹1,005 cr

P/E

33.8

P/B

5.1

ROE

16.7%

ROCE

18.4%

Debt / equity

0.1

Dividend yield

0.00%

1-year return

90.9%

52-week high

₹502.9

52-week low

₹210

Operating margin

27.5%

Growth

Revenue (last 12 months)	₹123 cr
Net profit (last 12 months)	₹29 cr
Sales growth, 3 years (yearly)	5.7%
Profit growth, 3 years (yearly)	-8.7%

Similar companies

Amrutanjan Health Care Limited (AMRUTANJAN) · Influx Healthtech Limited (INFLUX) · Lyka Labs Limited (LYKALABS) · Sat Kartar Life Limited (SATKARTAR) · Natural Capsules Limited (NATCAPSUQ)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SHRIAHIMSA in NSE Scanner →